BLACK WEEKSViaalid −15% · komplektid −10% · muu −5%koodigaTasuta tarne Saksamaal alates €200

See leht on tõlgitud automaatselt ja võib sisaldada vigu. Kas eesti keel on sinu emakeel? Ootame hea meelega sinu tagasisidet ja parandusi.Saada tagasisidet

The Peptide Desk The Peptide Desk
Thymosin Alpha-1, toote foto

Laboriaruanne

PDF
99%
Puhtus
Testitud
Thymosin Alpha-1 5mg
Labor
Analiza Białek
Kuupäev
November 2026
Tulemus
99% purity (5.33 mg measured)
Endotoksiinid
4.56 EU/vial
Tellimuse nr
Parool

Sõltumatult testitud, kontrollitav parooliga otse laboris.

Immune System

Thymosin Alpha-1

Immune System

Tellimus

Ühiku hind - Black Weeksi ajal tasuta tarne Saksamaal alates 200 €
  • DHL koos jälgimisega
  • Diskreetne pakend

4.6 5-st Trustpilotis73 arvustust

Lühidalt

Thymosin Alpha-1 arvudes

Põhinäitajad meie leksikonist.

Täielik leksikoni artikkel
Class
Immune-modulating peptidethymus-derived
Frequency
~2x per weekin phases
Form
Lyophilised powderreconstituted with BAC water
Sizes
5 to 10 mg2 sizes in the shop

Teadmised

Kõik teemal Thymosin Alpha-1

Telli kohe kaasa

Mida sul sellega vaja on

Bakteriostaatiline vesi lisatakse ostukorvi automaatselt. Süstlad ja lapid ühe klõpsuga.

Insuliinisüstlad

10 tk · 5.50 €

Alkoholilapid

50 tk · 10 €

Kui palju vett?

Ühikud süstlal sinu viaali suuruse jaoks.

Ava kalkulaator →

FAQ

Korduma kippuvad küsimused

Allikad iga vastuse juurde: leksikoni artikkel

Kas sul on veel küsimusi?

Kirjuta meile, meie meeskond aitab sind.

Is Thymosin Alpha-1 approved?

Yes, but not everywhere. As thymalfasin it is approved in over 35 countries according to a 2009 review, mainly for hepatitis B and C and to strengthen the immune system. There is no approval in the US, ChEMBL lists the compound at phase 3.

How does Thymosin Alpha-1 work?

In cell and mouse experiments it made dendritic cells more active, the cells that show pathogens to the immune system. This ran via the receptor TLR9. At the same time it promoted regulatory T cells, which slow down excessive reactions. ChEMBL lists no confirmed mechanism in humans.

What do the sepsis trials show?

In ETASS with 361 people 26 percent died within 28 days with Thymosin Alpha-1 and 35 percent without, a difference that just missed certainty. The larger TESTS trial with 1,106 people and placebo found 23.4 versus 24.1 percent, so no difference. A possible benefit from age 60 counts only as a hint there.

Are there data on cancer?

In a trial with 488 people with advanced melanoma Thymosin Alpha-1 was added to chemo. The highest study dose was 6.4 mg. More tumours responded and median survival was 9.4 versus 6.6 months, but not statistically certain. There were no extra side effects.

Does it help in severe pancreatitis?

Not with certainty in the TRACE trial with 508 people. Infected dead tissue occurred in 15.7 percent with Thymosin Alpha-1 and 18.1 percent on placebo. The main goal was therefore not reached.

Which side effects are known?

In TESTS 66.4 percent on Thymosin Alpha-1 and 67.6 percent on placebo had an adverse event, serious events were 26.8 versus 29.3 percent. ETASS recorded no serious side effects caused by the drug. With autoimmune disease the regular entry advises restraint.

Seotud

Seotud tooted